Growth Metrics

OmniAb (OABI) FCF Margin (2022 - 2026)

OmniAb (OABI) reported FCF Margin of 35.22% for Q1 2026, up 35190.0% year-over-year from N/an in Q1 2025, and up 48.09% on a QoQ basis from 67.85% in Q4 2025.

OmniAb (OABI) has 5 years of FCF Margin data on file, last reported at 35.22% in Q1 2026.

  • Quarterly FCF Margin rose 35190.0% year-over-year to 35.22% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 89.91% (up 5339.0% YoY) and the FY2025 annual result came in at 198.33%, down 4774.0% from the prior year.
  • FCF Margin advanced to 35.22% in Q1 2026 per OABI's latest filing, from 67.85% in the prior quarter.
  • Across five years, FCF Margin topped out at 162.27% in Q1 2023 and bottomed at 460.3% in Q1 2024.
  • The 5-year median for FCF Margin is 94.56% (2023), against an average of 131.73%.
  • The widest annual swing landed in 2024, when FCF Margin tumbled 62257 bps; it then soared 35190 bps in 2026.
  • Tracing OABI's FCF Margin over 5 years: stood at 10.2% in 2022, then sank by 1885 bps to 202.41% in 2023, then jumped by 90 bps to 19.62% in 2024, then plunged by 246 bps to 67.85% in 2025, then jumped by 48 bps to 35.22% in 2026.
  • Per Business Quant, the three latest OABI FCF Margin figures stand at 35.22% (Q1 2026), 67.85% (Q4 2025), and 444.17% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -3.98%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 43.35%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 23.53%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.17%
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn -35.22%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -35.22%
Dec 31, 2025 -67.85%
Sep 30, 2025 -444.17%
Jun 30, 2025 -136.28%
Mar 31, 2025 -387.12%
Dec 31, 2024 -19.62%
Sep 30, 2024 -197.79%
Jun 30, 2024 -155.94%
Mar 31, 2024 -460.30%
Dec 31, 2023 -202.41%
Sep 30, 2023 -94.56%
Jun 30, 2023 -155.99%
Mar 31, 2023 162.27%
Dec 31, 2022 -10.20%
Sep 30, 2022 -60.67%
Jun 30, 2022 -68.65%
Mar 31, 2022 95.09%